Insider Transactions in Q4 2023 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Bona fide gift
|
Direct |
1,785
-7.1%
|
-
|
|
Dec 13
2023
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
4,122
-5.18%
|
$309,150
$75.1 P/Share
|
|
Dec 13
2023
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,644
+6.43%
|
$225,760
$40.23 P/Share
|
|
Dec 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.49%
|
$555,000
$74.65 P/Share
|
|
Nov 28
2023
|
James R Tobin |
SELL
Open market or private sale
|
Indirect |
10,000
-4.11%
|
$700,000
$70.14 P/Share
|
|
Nov 17
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
5,714
-30.41%
|
-
|
|
Nov 07
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-2.83%
|
$960,000
$64.32 P/Share
|
|
Oct 02
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.02%
|
$270,000
$54.22 P/Share
|
|
Oct 02
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.37%
|
$80,000
$16.14 P/Share
|